The DZD will once again be represented with a booth at the EASD this year – together with the Danish Diabetes and Endocrinology Academy (DDEA). The DZD team cordially invites all interested parties to visit booth #14 in the Community Plaza from September 16 to 19, 2025, to network and learn more about current research projects and translational successes.
Career paths in diabetes research – participate and win!
Together with the German Diabetes Association (DDG), the DZD will also be providing information at its booth about career and funding opportunities in diabetes research in Germany. Young scientists are invited to participate in a contest for a chance to win one of five free tickets to the DDG Congress 2026.
“Meet the Expert” session & award ceremony: September 18, 3:00–3:30 p.m.
Recognition for young DZD scientist
Young researcher Dr. Martin Schön from the DZD partner German Diabetes Center in Düsseldorf will be honored at the EASD. He will receive both the EASD Rising Star Award and the EFSD Rising Star Fellowship. With the EFSD Rising Star Fellowship, the Novo Nordisk Foundation and the European Foundation for the Study of Diabetes (EFSD) support promising young scientists in the field of European diabetes research. The awards will be presented on September 18 at 8:30 a.m. during the EASD Rising Star Symposium.
Martin Schön is a postdoctoral researcher at the DZD site in Düsseldorf and works as a resident physician at the Department of Endocrinology and Diabetology at Heinrich Heine University Düsseldorf. At the symposium, he will present his work entitled “Exploring Diabetes Heterogeneity: Toward Mechanistic Insight, Improved Classification, and Clinical Translation.”
Presentation of current research highlights
Scientists from the DZD are well represented in the lecture and poster program of the EASD Congress. They will present the latest results of translational diabetes research in various symposia. The numerous contributions by DZD researchers cover topics such as early detection of type 1 diabetes, new risk factors for type 2 diabetes, use of genetics for new treatment approaches in type 2 diabetes and obesity, meal times and their role in obesity and related diseases, and glucagon regulation of energy metabolism.
